IRLAB: Final patient enrolled in Pirepemat study - Redeye
Bildkälla: Stockfoto

IRLAB: Final patient enrolled in Pirepemat study - Redeye

Redeye gives a short comment on today’s news that IRLAB has enrolledthe last patient in the ongoing phase IIb Pirepemat, in line with expectations

Redeye gives a short comment on today’s news that IRLAB has enrolledthe last patient in the ongoing phase IIb Pirepemat, in line with expectations
Börsvärldens nyhetsbrev
ANNONSER